Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment

Launched by ARTROMEDICAL KONRAD MALINOWSKI CLINIC · May 20, 2023

Keywords

ClinConnect Summary

**Clinical Trial Summary: PMTFI Treatment for Knee Pain**

This clinical trial is studying a treatment for a specific knee problem called Posteromedial Tibiofemoral Incongruence (PMTFI). People with this issue often experience pain, a snapping feeling, or discomfort behind the knee, especially when bending it during activities like squatting. The researchers want to see how effective this treatment is for improving these symptoms and the overall health of the knee joint.

To join the trial, participants should be between 65 and 74 years old and experience pain or discomfort in the back of the knee during deep knee bending. They will also need to have certain findings confirmed by an MRI and during a knee examination. However, those with active knee inflammation or severe cartilage injuries, among other specific conditions, won’t be eligible. If you participate, you can expect to undergo assessments and possibly receive the PMTFI treatment, while the research team collects data on how well it works. This study is currently looking for participants, so it could be a good opportunity for those suffering from these knee issues to seek relief.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat
• • Reduced concavity of the femoral metaphysis proximal to the medial femoral condyle confirmed on MRI
• • Impingement of posterior horn of medial meniscus with the metaphysis of femur during full knee flexion confirmed arthroscopically
• Exclusion Criteria:
• • Active knee inflammation
• • Chondral injuries ICRS 3-4
• • Extraarticular reasons of pain, snapping or discomfort in posterior part of the knee in deep knee flexion during squat
• • Cyst or avascular changes within the femoral metaphysis adjacent to the planned localization of the procedure